Department of Pharmacology and Physiology.
Snyder Institute for Chronic Diseases, and.
J Clin Invest. 2019 Jun 17;129(7):2629-2639. doi: 10.1172/JCI124616.
Neutrophils are the most abundant immune cells in humans and serve as first responders to a myriad of host perturbations. Equipped with a plethora of antimicrobial molecules, neutrophils invade sites of inflammation to eradicate pathogens and clear debris. Traditionally, neutrophils were thought to cause collateral tissue damage before dying at the site. However, the presence of neutrophil infiltration into sterile injuries (in the absence of infections) suggests additional roles for these cells. Now, the view of neutrophils as indiscriminate killers seems to be changing as evolving evidence suggests that neutrophils actively orchestrate resolution of inflammation and contribute to tissue repair. Novel concepts include the idea that neutrophils are key to revascularization and subsequently reverse-transmigrate back to the vasculature, actively leaving sites of tissue damage to re-home to functional niches in the lung and bone marrow. This Review scrutinizes the role of neutrophils in tissue damage and repair, discussing recent findings and raising unresolved questions around this intriguing immune cell.
中性粒细胞是人类体内最丰富的免疫细胞,作为应对宿主多种扰动的第一道防线。中性粒细胞拥有大量的抗菌分子,它们可以侵入炎症部位,消灭病原体并清除残骸。传统上,人们认为中性粒细胞在死亡前会在病灶处造成附带的组织损伤。然而,中性粒细胞在无菌性损伤(无感染)部位的浸润表明这些细胞具有额外的作用。现在,中性粒细胞作为不分青红皂白的杀手的观点似乎正在发生变化,因为不断涌现的证据表明,中性粒细胞积极地调控炎症的消退,并有助于组织修复。新的概念包括这样一种观点,即中性粒细胞是血管新生的关键,随后它们反向迁移回血管系统,积极离开组织损伤部位,返回到肺部和骨髓中的功能龛位。这篇综述仔细审查了中性粒细胞在组织损伤和修复中的作用,讨论了最近的发现,并提出了围绕这一有趣的免疫细胞的未解决问题。